Beijing Beilu Pharmaceutical Co., Ltd

Share · CNE000001QK9 (XSHE)

Overview

No Price

Closing Price XSHE 06.03.2026: 10,85 CNY

06.03.2026 07:04

Current Prices from Beijing Beilu Pharmaceutical Co., Ltd

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
SHENZHEN STOCK EXCHANGE	300016.SZ	CNY	06.03.2026 07:04	10,85 CNY	0,74 CNY +7,32 %

Share Float & Liquidity

Free Float 93,86 %

Shares Float 528,34 M

Shares Outstanding 562,87 M

Company Profile for Beijing Beilu Pharmaceutical Co., Ltd Share

Beijing Beilu Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. The company's products include contrast agents, central nervous system products, and oral anti-diabetic drugs. Beijing Beilu Pharmaceutical Co., Ltd. also produces precision medicine. The company was founded in 1992 and is based in Beijing, China.

AI Analysis of Beijing Beilu Pharmaceutical Co., Ltd

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Beijing Beilu Pharmaceutical Co., Ltd

No AI threads available for this company yet.

Company Data

Name Beijing Beilu Pharmaceutical Co., Ltd

Company Beijing Beilu Pharmaceutical Co., Ltd

Website https://www.beilu.com.cn

Primary Exchange

SHENZHEN STOCK EXCHANGE

ISIN CNE000001QK9

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Xu Wang

Market Capitalization 6 Mrd.

Country China

Currency CNY

Employees 1,2 T

Address Maples International Office, 100082 Beijing

IPO Date 2009-10-30

Ticker Symbols

Name	Symbol
SHENZHEN STOCK EXCHANGE	300016.SZ

More Shares

Investors who hold Beijing Beilu Pharmaceutical Co., Ltd also have the following shares in their portfolio:

BAWAG P.S.K. 23/31 MTN Bond

PORTUGAL 20/35 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog